Delivery Order SPE2DB20D2104-SPE2DB23FT20W
- Not listed
- This federal contract award is held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply the Defense Logistics Agency (DLA) with pharmaceutical products and medical supplies. The $1,344.94 delivery order contract for "EZETIMIBE 10 MG TABLET 500S" has an ultimate completion date of April 26, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,356.01, is for the delivery of ezetimibe 10 mg tablets, a pharmaceutical product used in the treatment of cardiovascular health conditions. The contract is a Firm Fixed Price Delivery Order that will run through June 3, 2024. This award is not associated with a set-aside program, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,383.94 firm fixed-price delivery order is for the supply of 4,567,304 units of the pharmaceutical product Ezetimibe 10 mg tablets. The contract has an ultimate completion date of February 19, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, with ID SPE2DB20D1109|SPE2DB24FP39H, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,392.86 Firm Fixed Price delivery order is for the provision of 4564996823 - EZETIMIBE 10 MG TABLET 500S. The contract has an ultimate completion date of June 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ezetimibe 10 mg tablets, a prescription medication, with a ceiling value of $1,146.21 and a performance period through March 2025. The contract is a delivery order, with a firm fixed price pricing type. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
- This federal contract award, valued at $1,140.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ezetimibe 10 mg tablets, a medication used to manage cholesterol levels. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC...
- The Defense Logistics Agency awarded a delivery order valued at $2,293.44 to AmerisourceBergen Drug Corp for 500 tablets of Ezetimibe 10 mg, with an ultimate completion date of February 5, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor...
- The federal contract award is for the delivery of ezetimibe-simvastatin 10-20 mg tablets to the Defense Logistics Agency (DLA). The $1,067.10 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This contract award, SPE2DB22D3004|SPE2DB24FPH74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,040.44 firm fixed-price delivery order is for the supply of 4563666654 EZETIMIBE 10 MG TABLET 500S, a pharmaceutical product. The contract has a period of performance through February 15, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award, with ID SPE2DB20D3101|SPE2DB21FK1T5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,637.31 firm fixed-price delivery order is for the supply of 4554366376 - Ezetimibe 10 mg Tablets, a medication used to manage cholesterol levels. The award is not designated under any set-aside program, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FT20WDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $2,909.70, is to provide 500 tablets of the drug ezetimibe 10 mg. The award has an ultimate completion date of April 25, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation covering similar medical products and prescription drugs. This award was not designated with any set-aside requirements, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 4/24/23 |